APRE (Aprea Therapeutics) Other Current Liabilities: $0.57 Mil (As of Mar. 2026)


APRE Aprea Therapeutics Inc APRE
26 GF Score
Price $0.74
! 1 Warning Sign
View Full Analysis

What is Aprea Therapeutics Other Current Liabilities?

Aprea Therapeutics APRE +2.77% 26 Other Current Liabilities is $0.57 Mil as of Mar. 2026. GuruFocus rates APRE with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Aprea Therapeutics's other current liabilities for the quarter that ended in Mar. 2026 was $0.57 Mil.

Aprea Therapeutics's quarterly other current liabilities increased from Sep. 2025 ($0.59 Mil) to Dec. 2025 ($0.77 Mil) but then declined from Dec. 2025 ($0.77 Mil) to Mar. 2026 ($0.57 Mil).

Aprea Therapeutics's annual other current liabilities declined from Dec. 2023 ($1.02 Mil) to Dec. 2024 ($0.47 Mil) but then increased from Dec. 2024 ($0.47 Mil) to Dec. 2025 ($0.77 Mil).

Aprea Therapeutics Other Current Liabilities Related Terms

Aprea Therapeutics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Aprea Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprea Therapeutics Other Current Liabilities Chart

Aprea Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only 1.42 1.40 1.02 0.47 0.77

Aprea Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.42 0.59 0.77 0.57
APRE
26GF Score
Aprea Therapeutics Inc APRE
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aprea Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.57 Mil mean?
Aprea Therapeutics (APRE) has a Other Current Liabilities of $0.57 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Aprea Therapeutics.
Is Aprea Therapeutics' Other Current Liabilities too high?
Aprea Therapeutics' current Other Current Liabilities is $0.57 Mil. Overall, Aprea Therapeutics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Aprea Therapeutics' Other Current Liabilities compare to JSPR and CVKD?
Aprea Therapeutics' Other Current Liabilities of $0.57 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Aprea Therapeutics. Aprea Therapeutics's current Other Current Liabilities is $0.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprea Therapeutics stock overvalued right now?
Aprea Therapeutics (APRE) has a current Other Current Liabilities of $0.57 Mil. The current Other Current Liabilities is $0.57 Mil. Aprea Therapeutics' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Aprea Therapeutics (APRE), the current Other Current Liabilities is $0.57 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprea Therapeutics Business Description

Address 3805 Old Easton Road, Doylestown, PA, USA, 18902
Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.
26GF Score

Get the complete analysis for APRE

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.74
Price